greeksoup/ stock research

Laureate Education, Inc.: Q1 FY2026 earnings call

What management said about Q1 FY2026, from the documents filed with the SEC on 30 April 2026: press release. Guidance figures: 1 raised, 1 lowered, 4 kept. The quarter’s numbers.

Key takeaways

  • New enrollments rose 9%: New enrollments rose 9% and total enrollments 6% for the first quarter. Through the intake cycle completed in April 2026, both measures were also up 9% and 6%. Source
  • Constant currency revenue grew 1%: Reported revenue rose 15% to $272.6 million, while constant currency revenue rose 1%. Constant currency excludes the period-over-period effect of currency fluctuations. Source
  • Peru revenue rose 32% reported: Peru revenue was $62.0 million, up 32% as reported and 21% in constant currency. Peru Adjusted EBITDA was $(34.9) million against $(38.8) million. New enrollments in Peru rose 13% in the primary intake. Source
  • Calendar timing cut about $9 million: Later semester start dates in 2026 reduced first-quarter revenue and Adjusted EBITDA by about $9 million each, compared with 2025. Source
  • Adjusted EBITDA was $(2.3) million: Adjusted EBITDA was $(2.3) million against $5.4 million. Management described the first quarter as seasonally low, and the year-on-year change was $(7.7) million. Source
  • About $105 million repurchased: Laureate repurchased about $105 million of common stock in the first quarter under the existing program. Payments for repurchases and excise tax totaled $108.2 million. Source
  • Adjusted EPS guidance raised: Adjusted EPS range is now $2.00 to $2.08, up from $1.95 to $2.03. Growth is now 16% to 21% as reported, against 13% to 18% before. Source

“We are pleased to report favorable new enrollment results from the recently completed primary intake cycle in Peru and the secondary intake cycle in Mexico.”

Eilif Serck-Hanssen, President and Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Total enrollments SourceFull-year 2026516,000 to 521,000 studentsKept
Revenues SourceFull-year 2026$1,890 million to $1,905 millionKept
Adjusted EBITDA SourceFull-year 2026$583 million to $593 millionKept
Adjusted EPS SourceFull-year 2026$2.00 - $2.08 per shareRaised from $1.95 - $2.03 per share
Diluted weighted average shares SourceFull-year 2026 (Adjusted EPS assumption)approximately 141 millionLowered from approximately 144 million
Foreign exchange assumption SourceMay 2026 to December 2026MXN 17.95 and PEN 3.45Kept

What changed from last quarter

  • Guidance raised: Adjusted EPS guidance raised to $2.00 to $2.08 from $1.95 to $2.03, with the update reflecting first-quarter repurchases. Source
  • Guidance lowered: Diluted share assumption reduced to about 141 million from about 144 million. Source

Enrollment and revenue growth

  • New enrollments rose 9%: New enrollments rose 9% and total enrollments 6% for the first quarter. Through the intake cycle completed in April 2026, both measures were also up 9% and 6%. Source
  • Constant currency revenue grew 1%: Reported revenue rose 15% to $272.6 million, while constant currency revenue rose 1%. Constant currency excludes the period-over-period effect of currency fluctuations. Source
  • Net loss was $21.6 million: Net loss was $21.6 million against $19.6 million a year earlier. Basic and diluted loss per share was $(0.15), compared with $(0.13) in the first quarter of 2025. Source

Segment results in Mexico and Peru

  • Peru revenue rose 32% reported: Peru revenue was $62.0 million, up 32% as reported and 21% in constant currency. Peru Adjusted EBITDA was $(34.9) million against $(38.8) million. New enrollments in Peru rose 13% in the primary intake. Source
  • Mexico revenue rose 11% reported: Mexico revenue was $210.6 million, up 11% as reported and down 4% in constant currency. Mexico Adjusted EBITDA was $41.5 million against $53.0 million. Mexico enrollments rose 4% in the secondary intake. Source

“Our operating trends remain on track with our expectations for the year.”

Eilif Serck-Hanssen, President and Chief Executive Officer

Operating loss and calendar timing

  • Calendar timing cut about $9 million: Later semester start dates in 2026 reduced first-quarter revenue and Adjusted EBITDA by about $9 million each, compared with 2025. Source
  • Operating loss widened to $27.5 million: Operating loss was $(27.5) million against $(13.2) million, a change of $14.3 million, driven mainly by calendar timing and higher depreciation and amortization. Source
  • Depreciation and amortization increased: Depreciation and amortization was $22.6 million against $16.1 million, linked to campus expansions and new campus investments. Source
  • Adjusted EBITDA was $(2.3) million: Adjusted EBITDA was $(2.3) million against $5.4 million. Management described the first quarter as seasonally low, and the year-on-year change was $(7.7) million. Source

Cash flow and balance sheet

  • Operating cash flow was $61.9 million: Net cash from operating activities was $61.9 million against $57.8 million. Purchases of property and equipment were $8.3 million against $4.6 million. Source
  • Net debt of $59.7 million: At March 31, 2026, cash was $157.4 million and gross debt $217.1 million, giving net debt of $59.7 million. Net cash was $17.6 million at December 31, 2025. Source
  • Net long-term borrowing of $71.5 million: Net increase in long-term debt was $71.5 million in the first quarter, against $7.5 million a year earlier. Total long-term debt including current portion was $215.8 million. Source

“As a result, we are increasing our full-year Adjusted Earnings Per Share guidance.”

Eilif Serck-Hanssen, President and Chief Executive Officer

Share repurchases and authorization

  • About $105 million repurchased: Laureate repurchased about $105 million of common stock in the first quarter under the existing program. Payments for repurchases and excise tax totaled $108.2 million. Source
  • About $76 million authorization remains: About $76 million of repurchase authorization remained at March 31, 2026. The February increase to $400 million had left about $181 million available at that time. Source
  • Shares outstanding fell to 140.0 million: Total shares outstanding were 140.0 million at March 31, 2026, against 142.9 million at December 31, 2025. Source

Full-year 2026 guidance

  • Adjusted EPS guidance raised: Adjusted EPS range is now $2.00 to $2.08, up from $1.95 to $2.03. Growth is now 16% to 21% as reported, against 13% to 18% before. Source
  • Revenue and Adjusted EBITDA ranges kept: Revenue stays at $1,890 million to $1,905 million, and Adjusted EBITDA stays at $583 million to $593 million, both as reported growth ranges. Source
  • Enrollment range kept: Total enrollments are still expected at 516,000 to 521,000 students, growth of 4% to 5% versus 2025. Source

Impact report and workforce

  • Annual Impact Report published: Management said it recently published its annual Impact Report, describing the difference made in students' lives and their families. Source
  • More than 30,000 faculty and staff: Management credited a team of more than 30,000 faculty and staff with embodying the company's values every day. Source
  • Five institutions, about 500,000 students: The company describes itself as operating five higher education institutions across Mexico and Peru, enrolling about 500,000 students. Source

Coming up, as management said on 30 April 2026

  • Calendar timing expected to offset in Q3: Management expects the calendar timing effects on revenue and Adjusted EBITDA to be offset in the third quarter of 2026. Source

Figures management reported

FigureReported
Laureate new enrollments, first quarter 2026 Source102,700, up 9% (timing-adjusted 9%)
Laureate total enrollments, March 31, 2026 Source507,700, up 6% (timing-adjusted 6%)
Peru new enrollments, first quarter 2026 Source57,400, up 15% (timing-adjusted 13%)
Mexico new enrollments, first quarter 2026 Source45,300, up 2% (timing-adjusted 4%)

Risks management discussed

  • Financial: Management said it cannot reconcile forward Adjusted EBITDA and Adjusted EPS to GAAP measures without unreasonable effort, because data is insufficient. Source

Earlier plans management reported on

  • On track: Management said operating trends remain on track with its expectations for the year. Source
  • Not stated: Management said the Adjusted EBITDA range of $583 million to $593 million is still expected, without a stated status against the earlier plan. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.